Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations

Vaccine

Volumn 31, Issue 46, 2013, Pages 5381-5391

  Yucesoy, Berran ^a   Talzhanov, Yerkebulan ^b   Johnson, Victor J ^c   Wilson, Nevin W ^d   Biagini, Raymond E ^a   Wang, Wei ^a   Frye, Bonnie ^a   Weissman, David N ^a   Germolec, Dori R ^e   Luster, Michael I ^f   Barmada, Michael M ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c BRT Burleson Research Technologies   (United States)

^d UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Childhood vaccine; Genetic polymorphism; Immune response; Major histocompatibility complex

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; GENOMIC DNA; HEPATITIS B VACCINE; HLA A ANTIGEN; HLA C ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB5 ANTIGEN; HLA G ANTIGEN; IMMUNOGLOBULIN G; MICROSPHERE;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINATION;

CHILDHOOD VACCINE; CPS; DIPHTHERIA, TETANUS, AND PERTUSSIS; DTAP; GENETIC POLYMORPHISM; HAEMOPHILUS INFLUENZA TYPE B; HBSAG; HBV; HEPATITIS B VIRUS; HEPTAVALENT PNEUMOCOCCAL CONJUGATE; HIB; HLA; HUMAN LEUKOCYTE ANTIGEN; IG; IMMUNE RESPONSE; IMMUNOGLOBULIN; INACTIVATED POLIO VACCINE; IPV; LD; LINKAGE DISEQUILIBRIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MHC; ODDS RATIO; OR; PCV7; PNEUMOCOCCAL CELL WALL POLYSACCHARIDE; PNEUMOCOCCAL POLYSACCHARIDES; PNPS; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; SURFACE ANTIGEN OF HEPATITIS B VIRUS;

ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INFANT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PNEUMOCOCCAL VACCINES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84886095100     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.09.026     Document Type: Article

References (46)

1. Zuckerman J.N. Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production. J Med Virol 1996, 50(4):283-288.
2. Poland G.A., Jacobson R.M., Colbourne S.A., Thampy A.M., Lipsky J.J., Wollan P.C., et al. Measles antibody seroprevalence rates among immunized Inuit, Innu and Caucasian subjects. Vaccine 1999, 17(11-12):1525-1531.
3. Milich D.R., Leroux-Roels G.G. Immunogenetics of the response to HBsAg vaccination. Autoimmun Rev 2003, 2(5):248-257.
4. Poland G.A., Jacobson R.M. The genetic basis for variation in antibody response to vaccines. Curr Opin Pediatr 1998, 10(2):208-215.
5. Godkin A., Davenport M., Hill A.V. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 2005, 41(6):1383-1390.
6. McDermott A.B., Zuckerman J.N., Sabin C.A., Marsh S.G., Madrigal J.A. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997, 50(1):8-14.
7. Png E., Thalamuthu A., Ong R.T., Snippe H., Boland G.J., Seielstad M. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Genet 2011, 20(19):3893-3898.
8. Yucesoy B., Sleijffers A., Kashon M., Garssen J., de Gruijl F.R., Boland G.J., et al. IL-1beta gene polymorphisms influence hepatitis B vaccination. Vaccine 2002, 20(25/26):3193-3196.
9. Wang C., Tang J., Song W., Lobashevsky E., Wilson C.M., Kaslow R.A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004, 39(4):978-988.
10. Chen J., Liang Z., Lu F., Fang X., Liu S., Zeng Y., et al. Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine. Vaccine 2011, 29(4):706-711.
11. Yucesoy B., Johnson V.J., Fluharty K., Kashon M.L., Slaven J.E., Wilson N.W., et al. Influence of cytokine gene variations on immunization to childhood vaccines. Vaccine 2009, 27(50):6991-6997.
12. Human Traherne J.A. MHC architecture and evolution: implications for disease association studies. Int J Immunogenet 2008, 35(3):179-192.
13. Neefjes J., Jongsma M.L., Paul P., Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 2011, 11(12):823-836.
14. Walker W.G., Hillis W.D., Hillis A. Hepatitis B infection in patients with end stage renal disease: some characteristics and consequences. Trans Am Clin Climatol Assoc 1981, 92:142-151.
15. Craven D.E., Awdeh Z.L., Kunches L.M., Yunis E.J., Dienstag J.L., Werner B.G., et al. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med 1986, 105(3):356-360.
16. Milich D., Liang T.J. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003, 38(5):1075-1086.
17. Desombere I., Willems A., Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 1998, 51(6):593-604.
18. Watanabe H., Matsushita S., Kamikawaji N., Hirayama K., Okumura M., Sasazuki T. Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells. Hum Immunol 1988, 22(1):9-17.
19. Lango-Warensjo A., Cardell K., Lindblom B. Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen. Tissue Antigens 1998, 52(4):374-380.
20. De Silvestri A., Pasi A., Martinetti M., Belloni C., Tinelli C., Rondini G., et al. Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus. Genes Immun 2001, 2(7):367-372.
21. Jacobson R.M., Poland G.A., Vierkant R.A., Pankratz V.S., Schaid D.J., Jacobsen S.J., et al. The association of class I HLA alleles and antibody levels after a single dose of measles vaccine. Hum Immunol 2003, 64(1):103-109.
22. Ovsyannikova I.G., Jacobson R.M., Dhiman N., Vierkant R.A., Pankratz V.S., Poland G.A. Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics 2008, 121(5):e1091-e1099.
23. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., Poland G.A. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis 2005, 191(4):515-519.
24. Gelder C.M., Lambkin R., Hart K.W., Fleming D., Williams O.M., Bunce M., et al. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J Infect Dis 2002, 185(1):114-117.
25. Ovsyannikova I.G., Pankratz V.S., Vierkant R.A., Jacobson R.M., Poland G.A. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. J Infect Dis 2006, 193(5):655-663.
26. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., O'Byrne M.M., Poland G.A. Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations. Vaccine 2009, 27(49):6926-6931.
27. CDC Notice to Readers: recommended Childhood Immunization Schedule - United States, 2002. MMWR 2002, 31-33.
28. Schlottmann S.A., Jain N., Chirmule N., Esser M.T. A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheres. J Immunol Methods 2006, 309(1-2):75-85.
29. Biagini R.E., Sammons D.L., Smith J.P., MacKenzie B.A., Striley C.A., Semenova V., et al. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins. Clin Diagn Lab Immunol 2004, 11(1):50-55.
30. Biagini R.E., Schlottmann S.A., Sammons D.L., Smith J.P., Snawder J.C., Striley C.A., et al. Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides. Clin Diagn Lab Immunol 2003, 10(5):744-750.
31. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(3):559-575.
32. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
33. Johnson A.D., Handsaker R.E., Pulit S.L., Nizzari M.M., O'Donnell C.J., de Bakker P.I. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008, 24(24):2938-2939.
34. Boyle A.P., Hong E.L., Hariharan M., Cheng Y., Schaub M.A., Kasowski M., et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012, 22(9):1790-1797.
35. International HapMap 3 Consortium, Altshuler D.M., Gibbs R.A., Peltonen L., Altshuler D.M., Gibbs R.A., et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010, 467(7311):52-58.
36. Ovsyannikova I.G., Pankratz V.S., Vierkant R.A., Jacobson R.M., Poland G.A. Consistency of HLA associations between two independent measles vaccine cohorts: a replication study. Vaccine 2012, 30(12):2146-2152.
37. Pajewski N.M., Parker S.D., Poland G.A., Ovsyannikova I.G., Song W., Zhang K., et al. The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed. Genes Immun 2011, 12(6):457-465.
38. Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Jacobson R.M., Poland G.A. Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine. J Infect Dis 2011, 203(11):1546-1555.
39. Li Y., Ni R., Song W., Shao W., Shrestha S., Ahmad S., et al. Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet 2009, 126(5):685-696.
40. Lankat-Buttgereit B., Tampe R. The transporter associated with antigen processing: function and implications in human diseases. Physiol Rev 2002, 82(1):187-204.
41. Hayney M.S., Poland G.A., Dimanlig P., Schaid D.J., Jacobson R.M., Lipsky J.J. Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus. Vaccine 1997, 15(1):3-6.
42. Poland G.A. Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response. Am J Hum Genet 1998, 62(2):215-220.
43. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008, 111(10):4862-4870.
44. Carosella E.D., Moreau P., Lemaoult J., Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008, 29(3):125-132.
45. Eike M.C., Becker T., Humphreys K., Olsson M., Lie B.A. Conditional analyses on the T1DGC MHC dataset: novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B. Genes Immun 2009, 10(1):56-67.
46. Yan W.H., Lin A., Chen B.G., Chen S.Y. Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. J Infect Dis 2009, 200(5):820-826.